UMedic has prospective earnings growth over the next two years


UMediC Group Bhd's manufacturing plant in Batu Kawan, Penang.

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen.

In a report, the research house said the fast growing distributor of medical equipment and manufacturer of medical consumables is backed by solid prospective earnings growth over the next two years.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic

Next In Business News

Stocks, dollar take tariff hit; gold gets safety bid
Malaysian economy to stay resilient in 2026 on FDI, robust infrastructure investment- HSBC�
FBM KLCI slips as traders turn cautious on growing geopolitical tension
Bursa Malaysia suspends short-selling of SMRT due to price limit breach
SMRT's share price dives on sharp earnings downgrade
MAHB 2025 passenger traffic reaches 15.53mil as VM2026 kicks off
China's Q4 GDP growth slows to 3-year low, full-year pace meets official target
World markets jolted, dollar dips as Trump vows tariffs on Europe over Greenland
Oil prices steady as ebbing Iranian protests lower chance of US attack
Foreign funds log second straight week of net inflows of RM716.1mil

Others Also Read